To date, more than 60 patients with AUTS2 syndrome have been described in the literature and most of them carry an intragenic de novo deletion of AUTS2, whereas point mutations leading to the disease are rarely described (Sanchez-Jimeno et al., 2021). This evidence concerns the gene AUTS2 and autism spectrum disorder due to AUTS2 deficiency.